[{"arm_notes": "", "treatment_id": null, "treatment_name": "ABO blood group compatible high neutralizing antibodies titer (equal or more than 1 per 320) COVID19 Convalescent plasma (CCP) from National Blood Centre Thai Red Cross Society from male donors with pathogen inactivationCCP 250 ml infusion in 2 hours in recipient with bodyweight less than 60 kgCCP 300 ml infusion in 2 hours in recipient with bodyweight more than or equal 60 kgCombined with 1800 mg of favipiravir loading two times on the first day then 800 mg of favipiravir then 800 mg two times on day 2 to 5 or 2400 mg of favipiravir two times a day in the first day then 1000 mg 2 times a day on day 2 to 5 in obese patients with bodyweight more than 90 kg or BMI more than or equal 30 kg per meter square ;Intravenous sotrovimab 500 mg infusion in 30 to 60 minutes single dose;Experimental Drug;Active Comparator Drug;High neutralizing antibodies titer of COVID19 convalescent plasma therapy plus favipiravir;Sotrovimab", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2432, "treatment_name": "Convalescent plasma+favipiravir", "treatment_type": "Convalescent plasma+antivirals", "pharmacological_treatment": "Biological treatment+pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1859, "treatment_name": "Sotrovimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}]